Literature DB >> 18249157

Anxiety and cognitive effects of quercetin liposomes in rats.

Aroonsri Priprem1, Jintanaporn Watanatorn, Saengrawee Sutthiparinyanont, Wathita Phachonpai, Supaporn Muchimapura.   

Abstract

Quercetin, an effective flavonol used as an antioxidant, was investigated for its anxiolytic and cognitive activities in male Wistar rats. Oral quercetin (300 mg/kg body weight/day) was compared with oral and intranasal quercetin liposomes (20 microg/day). Quercetin liposomes, in a mixture of egg phosphatidylcholine, cholesterol, and quercetin (2:1:1) and dispersed in 50% polyethylene glycol in water, were approximately 200 nm in mean particle diameter and negative surface charge with a range of encapsulation efficiency of 60% to 80%. Anxiolytic and cognitive-enhancing effects of quercetin, conventional and liposomal, were subjected to elevated plus maze and Morris water maze tests, respectively. Both conventional and quercetin liposomes showed anxiolytic and cognitive-enhancing effects. A lower dose and a faster rate were observed with intranasal quercetin liposomes when compared with oral quercetin, conventional and liposomal. The intranasal quercetin liposomes are effective in the delivery of quercetin to the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18249157     DOI: 10.1016/j.nano.2007.12.001

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  23 in total

1.  The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.

Authors:  Angélica Maria Sabogal-Guáqueta; Juan Ignacio Muñoz-Manco; Jose R Ramírez-Pineda; Marisol Lamprea-Rodriguez; Edison Osorio; Gloria Patricia Cardona-Gómez
Journal:  Neuropharmacology       Date:  2015-02-07       Impact factor: 5.250

Review 2.  Bioavailability enhancers of herbal origin: an overview.

Authors:  Kritika Kesarwani; Rajiv Gupta; Alok Mukerjee
Journal:  Asian Pac J Trop Biomed       Date:  2013-04

3.  Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model.

Authors:  Deepak Chitkara; Sanjay K Nikalaje; Anupama Mittal; Mahesh Chand; Neeraj Kumar
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

4.  Anxiolytic-like effects of α-asarone in a mouse model of chronic pain.

Authors:  Jiao Tian; Zhen Tian; Shu-Li Qin; Pu-Yu Zhao; Xun Jiang; Zhen Tian
Journal:  Metab Brain Dis       Date:  2017-09-15       Impact factor: 3.584

5.  The effects of quercetin supplementation on cognitive functioning in a community sample: a randomized, placebo-controlled trial.

Authors:  Joshua J Broman-Fulks; Will H Canu; Krystal L Trout; David C Nieman
Journal:  Ther Adv Psychopharmacol       Date:  2012-08

6.  Quercetin mitigates Adriamycin-induced anxiety- and depression-like behaviors, immune dysfunction, and brain oxidative stress in rats.

Authors:  Sameha Merzoug; Mohamed Lamine Toumi; Abdelkrim Tahraoui
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06-20       Impact factor: 3.000

Review 7.  Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease.

Authors:  Farida El Gaamouch; Kalena Liu; Hsiao-Yun Lin; Clark Wu; Jun Wang
Journal:  Neurochem Int       Date:  2021-04-16       Impact factor: 4.297

8.  Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats.

Authors:  Mayur Bagad; Zaved Ahmed Khan
Journal:  Int J Nanomedicine       Date:  2015-06-10

Review 9.  Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-27

10.  Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer.

Authors:  Bee-Jen Tan; Yuanjie Liu; Kai-Lun Chang; Bennie K W Lim; Gigi N C Chiu
Journal:  Int J Nanomedicine       Date:  2012-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.